Discussions on with Indian government for expedited approval of COVID-19 vaccine: Pfizer

Discussions on with Indian government for expedited approval of COVID-19 vaccine: Pfizer
Pfizer had earlier said that it had offered a not-for-profit price for its vaccine for the immunisation programme in India and it remains committed to continuing engagement with the government.
Share Via Email
  |  A+A A-
By PTI
NEW DELHI: Pfizer is in discussions with the Indian government for an expedited approval pathway to make Pfizer-BioNTech vaccine available in the country, its chief Albert Bourla said on Monday, while stating that the firm is donating medicines worth USD 70 million (over Rs 510 crore) for treatment of COVID-19 patients in India.

Related Keywords

Japan ,United States ,India ,Canada ,United Kingdom ,Albert Bourla ,Pfizer ,Linkedin ,Regulatory Agency United Kingdom ,European Medicines Agency ,Device Agency ,Drug Administration ,Global Pharma ,Pfizer India ,United States Food ,United Kingdom Medicines ,Regulatory Agency ,Medical Device Agency ,Covid 19 ,India Covid Vaccines ,ஜப்பான் ,ஒன்றுபட்டது மாநிலங்களில் ,இந்தியா ,கனடா ,ஒன்றுபட்டது கிஂக்டம் ,ஃபைசர் ,சென்டர் ,உலகளாவிய பார்மா ,ஃபைசர் இந்தியா ,ஒன்றுபட்டது மாநிலங்களில் உணவு ,ஒன்றுபட்டது கிஂக்டம் மருந்துகள் ,விட் ,